Beauty Farm Medical and Health Industry Inc. disclosed a fresh on-market buyback of 40,000 ordinary shares on 28 September 2026, executed on the Hong Kong Stock Exchange under its existing repurchase mandate approved on 26 June 2026.

The shares were repurchased at prices ranging between HKD 18.40 and HKD 18.71, translating into a volume-weighted average cost of HKD 18.61 per share and an aggregate consideration of HKD 0.74 million. Post-transaction, the company’s treasury stock rose to 3.94 million shares, while outstanding shares decreased to 247.65 million, representing a 0.016 percent reduction versus the previous day’s balance.

Since the mandate took effect, Beauty Farm has bought back 868,500 shares—equivalent to 0.35 percent of the 248.52 million shares outstanding when the mandate was granted—leaving capacity to repurchase up to 23.98 million additional shares. The total issued share capital, inclusive of treasury shares, remains unchanged at 251.59 million.

In accordance with Hong Kong listing rules, the company is subject to a 30-day moratorium on issuing new shares or selling treasury shares, ending 28 October 2026. Beauty Farm confirmed that all repurchase activities were executed in compliance with the Main Board Listing Rules, applicable regulations, and the conditions of its explanatory statement filed in May 2026.